Open Access
CC BY-NC-ND 4.0 · Endosc Int Open 2020; 08(06): E733-E737
DOI: 10.1055/a-1135-8804
Innovation forum

Technical feasibility and safety of transluminal antegrade dilation for hepaticojejunostomy stricture using a novel fine-gauge electrocautery dilator (with video)

Authors

  • Takeshi Ogura

    1   2nd Department of Internal Medicine, Osaka Medical College, Osaka, Japan
  • Nobu Nishioka

    1   2nd Department of Internal Medicine, Osaka Medical College, Osaka, Japan
  • Masanori Yamada

    1   2nd Department of Internal Medicine, Osaka Medical College, Osaka, Japan
  • Tadahiro Yamada

    1   2nd Department of Internal Medicine, Osaka Medical College, Osaka, Japan
  • Saori Ueno

    1   2nd Department of Internal Medicine, Osaka Medical College, Osaka, Japan
  • Jyun Matsuno

    1   2nd Department of Internal Medicine, Osaka Medical College, Osaka, Japan
  • Kazuya Ueshima

    1   2nd Department of Internal Medicine, Osaka Medical College, Osaka, Japan
  • Yoshitaro Yamamoto

    1   2nd Department of Internal Medicine, Osaka Medical College, Osaka, Japan
  • Atsushi Okuda

    1   2nd Department of Internal Medicine, Osaka Medical College, Osaka, Japan
  • Reiko Ashida

    2   Departments of Cancer Survey and Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, Japan
  • Kazuhide Higuchi

    1   2nd Department of Internal Medicine, Osaka Medical College, Osaka, Japan

Abstract

Background and study aims A novel fine-gauge electrocautery dilator (ED) has recently become available in Japan. The current study evaluated the safety and feasibility of transluminal antegrade dilation for hepaticojejunal stricture (HJS) using this novel ED.

Patients and methods Patients who with complicated HJS were retrospectively enrolled. The primary and secondary endpoints of this study were rates of technical success defined as functional antegrade HJS dilation using the novel ED and types of adverse events, respectively. A total of 22 patients were enrolled. Among them, six were treated using an enteroscopic approach due to the absence of bile duct dilation or patient refusal to undergo EUS-HGS. Therefore, 16 patients underwent EUS-HGS.

Results The procedure was successful in 15 of 16 patients (93.8 %). The contrast medium flowed from the intrahepatic bile duct to the intestine of 14 of 15 patients (93.3 %). The resolution rate of HJS was 13 of 14 (92.9 %) at 6 months.

Conclusion Our technique might offer a new option with which to treat HJS, although a prospective study with long-term follow-up is needed.



Publication History

Received: 11 December 2019

Accepted: 25 February 2020

Article published online:
25 May 2020

© 2020. Owner and Copyright ©

© Georg Thieme Verlag KG
Stuttgart · New York